TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >800nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >800nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >800nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 600nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 600nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <400nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >800nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 600nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >800nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 3.50E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 3.50E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair